Radiation dosimetry of the fibrin-binding probe 64Cu-FBP8 and Its feasibility for PET imaging of deep vein thrombosis and pulmonary embolism in rats

Journal of Nuclear Medicine

Volumn 56, Issue 7, 2015, Pages 1088-1093

  Blasi, Francesco ^a   Oliveira, Bruno L ^a   Rietz, Tyson A ^a   Rotile, Nicholas J ^a   Day, Helen ^a   Naha, Pratap C ^b   Cormode, David P ^b   Izquierdo Garcia, David ^a   Catana, Ciprian ^a   Caravan, Peter ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dosimetry; DVT PE; Fibrin; PET imaging; Thrombosis

Indexed keywords

3 CHLOROTYROSINE; ACETIC ACID; CONTRAST MEDIUM; COPPER 64; FBP8 CU 64; FERRIC CHLORIDE; FIBRIN; GLUTARIC ACID; HYDROXYPROLINE; UNCLASSIFIED DRUG; COPPER;

ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; BLOOD CLOT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOSIMETRY; DRUG CLEARANCE; EX VIVO STUDY; FEASIBILITY STUDY; FEMALE; FEMORAL VEIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; KIDNEY; LIVER; LUNG EMBOLISM; MALE; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIOACTIVITY; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMALL INTESTINE; WESTERN BLOTTING; ALGORITHM; ANIMAL; CHEMISTRY; PROCEDURES; RADIOMETRY; SCINTISCANNING; SPRAGUE DAWLEY RAT; THROMBOSIS; TISSUE DISTRIBUTION; VEIN THROMBOSIS; WHOLE BODY IMAGING;

ALGORITHMS; ANIMALS; COPPER RADIOISOTOPES; FEMALE; FIBRIN; MALE; POSITRON-EMISSION TOMOGRAPHY; PULMONARY EMBOLISM; RADIOMETRY; RATS; RATS, SPRAGUE-DAWLEY; THROMBOSIS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENOUS THROMBOSIS; WHOLE BODY IMAGING;

EID: 84936773531     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.115.157982     Document Type: Article

References (38)

1. Fedullo PF, Tapson VF. Clinical practice: The evaluation of suspected pulmonary embolism. N Engl J Med. 2003;349:1247-1256.
2. Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006;354:2317-2327.
3. Ruiz Y, Caballero P, Caniego JL, et al. Prospective comparison of helical CT with angiography in pulmonary embolism: global and selective vascular territory analysis-lnterobserver agreement. Eur Radiol. 2003;13:823-829.
4. PIOPED. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA. 1990;263:2753-2759.
5. Anderson DR, Kahn SR, Rodger MA, et al. Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: A randomized controlled trial. JAMA. 2007;298:2743-2753.
6. Brotman DJ, Segal JB, Jani JT, Petty BG, Kickler TS. Limitations of D-dimer testing in unselected inpatients with suspected venous thromboembolism. Am J Med. 2003;114:276-282.
7. Heijboer H, Jongbloets LM, Buller HR, Lensing AW, ten Cate JW. Clinical utility of real-time compression ultrasonography for diagnostic management of patients with recurrent venous thrombosis. Acta Radiol. 1992;33:297-300.
8. Bounameaux H, Righini M, Perrier A. Venous thromboembolism: contemporary diagnostic and therapeutic aspects. Vasa. 2008;37:211-226.
9. Mehta BP, Nogueira RG. Should clot composition affect choice of endovascular therapy? Neurology. 2012;79:S63-S67.
10. Lindner JR. Molecular imaging of thrombus: technology in evolution. Circulation. 2012;125:3057-3059.
11. Ciesienski KL, Caravan P. Molecular MRI of thrombosis. Curr Cardiovasc Imaging Rep. 2010;4:77-84.
12. Uppal R, Catana C, Ay I, Benner T, Sorensen AG, Caravan P. Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe: feasibility study in rat model. Radiology. 2011;258:812-820.
13. Ciesienski KL, Yang Y, Ay I, et al. Fibrin-targeted PET probes for the detection of thrombi. Mol Pharm. 2013;10:1100-1110.
14. Boros E, Rybak-Akimova E, Holland JP, et al. Pycup: A bifunctional, cage-like ligand for 64Cu radiolabeling. Mol Pharm. 2014;11:617-629.
15. Ay I, Blasi F, Rietz TA, et al. In vivo molecular imaging of thrombosis and thrombolysis using a fibrin-binding positron emission tomographic probe. Circ Cardiovasc Imaging. 2014;7:697-705.
16. Blasi F, Oliveira BL, Rietz TA, et al. Effect of chelate type and radioisotope on the imaging efficacy of 4 fibrin-specific PET probes. J Nucl Med. 2014;55: 1157-1163.
17. Kolodziej AF, Nair SA, Graham P, et al. Fibrin specific peptides derived by phage display: characterization of peptides and conjugates for imaging. Bioconjug Chem. 2012;23:548-556.
18. Overoye-Chan K, Koerner S, Looby RJ, et al. EP-2104R: A fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus. J Am Chem Soc. 2008;130: 6025-6039.
19. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington, DC: National Academy Press; 2011.
20. Clozel JP, Holvoet P, Tschopp T. Experimental pulmonary embolus in the rat: A new in vivo model to test thrombolytic drugs. J Cardiovasc Pharmacol. 1988;12: 520-525.
21. Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res. 1990;60:269-280.
22. Cai QY, Kim SH, Choi KS, et al. Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice. Invest Radiol. 2007;42: 797-806.
23. Loening AM, Gambhir SS. AMIDE: A free software tool for multimodality medical image analysis. Mol Imaging. 2003;2:131-137.
24. Lendrum AC, Fraser DS, Slidders W, Henderson R. Studies on the character and staining of fibrin. J Clin Pathol. 1962;15:401-413.
25. Saha P, Andia ME, Modarai B, et al. Magnetic resonance T1 relaxation time of venous thrombus is determined by iron processing and predicts susceptibility to lysis. Circulation. 2013;128:729-736.
26. Phinikaridou A, Andia M, Saha P, Modarai B, Smith A, Botnar R. In vivo magnetization transfer and diffusion-weighted magnetic resonance imaging detects thrombus composition in a mouse model of deep vein thrombosis. Circ Cardiovasc Imaging. 2013;6:433-440.
27. Andia ME, Saha P, Jenkins J, et al. Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis. Arterioscler Thromb Vasc Biol. 2014;34:1193-1198.
28. Lee HB, Blaufox MD. Blood volume in the rat. J Nucl Med. 1985;26:72-76.
29. Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health. 1997;13:407-484.
30. Kirschner AS, Ice RD, Beierwaltes WH. Radiation dosimetry of 131I-19-iodocholesterol. J Nucl Med. 1973;14:713-717.
31. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: The second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023-1027.
32. Morris TA, Gerometta M, Yusen RD, et al. Detection of pulmonary emboli with 99mTc-labeled anti-D-dimer (DI-80B3)Fab' fragments (ThromboView). Am J Respir Crit Care Med. 2011;184:708-714.
33. Douketis JD, Ginsberg JS, Haley S, et al. Accuracy and safety of 99mTc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView(R)) in the diagnosis of deep vein thrombosis: A phase II study. Thromb Res. 2012;130:381-389.
34. Zierler BK. Ultrasonography and diagnosis of venous thromboembolism. Circulation. 2004;109:I9-I14.
35. Brommer EJ, Potter van Loon BJ, Rijken DC, van Bockel JH. Composition and susceptibility to thrombolysis of pathological human arterial thrombi. Ann N Y Acad Sci. 1992;667:283-285.
36. Hays MT, Watson EE, Thomas SR, Stabin M. MIRD dose estimate report no. 19: radiation absorbed dose estimates from 18F-FDG. J Nucl Med. 2002;43: 210-214.
37. Sandström M, Velikyan I, Garske-Roman U, et al. Comparative biodistribution and radiation dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumors. J Nucl Med. 2013;54:1755-1759.
38. Laforest R, Dehdashti F, Lewis JS, Schwarz SW. Dosimetry of 60/61/62/64Cu-ATSM: A hypoxia imaging agent for PET. Eur J Nucl Med Mol Imaging. 2005;32:764-770.